The deal with Sprout Pharmaceuticals was announced a day after the Food and Drug Administration approved first female sexual dysfunction drug Addyi

Valeant Pharmaceuticals will pay about $1bn to buy Sprout Pharmaceuticals, the maker of the first prescription drug intended to boost sexual desire in women.

The deal announced on Thursday comes a day after US regulators approved the pill.

Continue reading…
Source: The Guardian Circular Economy RSS